Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors

被引:117
作者
Serrano, Antonia [1 ,2 ]
Parsons, Loren H. [1 ]
机构
[1] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA
[2] Hosp Reg Univ Carlos Haya, Lab Med Regenerativa, Fdn IMABIS, Malaga 29010, Spain
关键词
Endocannabinoid; CB1; receptor; Addiction; Craving; Relapse; Synaptic plasticity; CANNABINOID CB1 RECEPTOR; ACID-AMIDE-HYDROLASE; VENTRAL TEGMENTAL AREA; CONDITIONED PLACE PREFERENCE; ANXIETY-LIKE BEHAVIOR; LONG-TERM DEPRESSION; DISCRIMINATIVE STIMULUS FUNCTIONS; NICOTINE-SEEKING BEHAVIOR; MEDIAL PREFRONTAL CORTEX; INDUCED DOPAMINE RELEASE;
D O I
10.1016/j.pharmthera.2011.06.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The endogenous cannabinoid system is an important regulatory system involved in physiological homeostasis. Endocannabinoid signaling is known to modulate neural development, immune function, metabolism, synaptic plasticity and emotional state. Accumulating evidence also implicates brain endocannabinoid signaling in the etiology of drug addiction which is characterized by compulsive drug seeking, loss of control in limiting drug intake, emergence of a negative emotional state in the absence of drug use and a persistent vulnerability toward relapse to drug use during protracted abstinence. In this review we discuss the effects of drug intake on brain endocannabinoid signaling, evidence implicating the endocannabinoid system in the motivation for drug consumption, and drug-induced alterations in endocannabinoid function that may contribute to various aspects of addiction including dysregulated synaptic plasticity, increased stress responsivity, negative affective states, drug craving and relapse to drug taking. Current knowledge of genetic variants in endocannabinoid signaling associated with addiction is also discussed. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:215 / 241
页数:27
相关论文
共 548 条
[1]  
Aceto MD, 1998, J PHARMACOL EXP THER, V287, P598
[2]  
Adamczyk P, 2009, J PHYSIOL PHARMACOL, V60, P119
[3]  
Adamczyki P, 2008, J PHYSIOL PHARMACOL, V59, P217
[4]  
Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209
[5]  
Adermark L, 2011, NEUROPHARMACOLOGY
[6]   Frequency-Dependent Inversion of Net Striatal Output by Endocannabinoid-Dependent Plasticity at Different Synaptic Inputs [J].
Adermark, Louise ;
Lovinger, David M. .
JOURNAL OF NEUROSCIENCE, 2009, 29 (05) :1375-1380
[7]   Evidence for Association Between Polymorphisms in the Cannabinoid Receptor 1 (CNR1) Gene and Cannabis Dependence [J].
Agrawal, Arpana ;
Wetherill, Leah ;
Dick, Danielle M. ;
Xuei, Xiaoling ;
Hinrichs, Anthony ;
Hesselbrock, Victor ;
Kramer, John ;
Nurnberger, John I., Jr. ;
Schuckit, Marc ;
Bierut, Laura J. ;
Edenberg, Howard J. ;
Foroud, Tatiana .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2009, 150B (05) :736-740
[8]   Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats [J].
Aguiar, Daniele C. ;
Terzian, Ana Luisa B. ;
Guimares, Francisco S. ;
Moreira, Fabricio A. .
PSYCHOPHARMACOLOGY, 2009, 205 (02) :217-225
[9]   Enzymatic pathways that regulate endocannabinoid signaling in the nervous system [J].
Ahn, Kay ;
McKinney, Michele K. ;
Cravatt, Benjamin F. .
CHEMICAL REVIEWS, 2008, 108 (05) :1687-1707
[10]   Pharmacological activation of CB1 and D2 receptors in rats:: predominant role of CB1 in the increase of alcohol relapse [J].
Alen, Francisco ;
Moreno-Sanz, Guillermo ;
de Tena, Ana Isabel ;
Brooks, Rayna D. ;
Lopez-Jimenez, Alejandro ;
Navarro, Miguel ;
Lopez-Moreno, Jose Antonio .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 27 (12) :3292-3298